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formed after helical computed tomographic pulmonary
angiography (CTPA) for suspected PE.11 Disagreement
exists about the use of CTV rather than US for the diag-
nosis of DVT during evaluation for PE. Although US has
been the LE imaging study of choice in this setting, CTV
combined with CTPA has been proposed as a single, rapid,
accurate, and possibly cost-effective alternative means of
evaluating both PE and LE-DVT, requiring no additional
contrast than that needed for CTPA alone.12,13 By using
US as the reference, we undertook this study to define the
usefulness of CTV in the diagnosis of acute LE-DVT and
to evaluate the direct costs of CTV.
METHODS
A retrospective review of all patients who underwent
US for suspected LE-DVT at the University of Michigan
Health System from May 1999 through September 2000
yielded 149 patients who also underwent CTV. Thirteen
patients were excluded from the study because there was a
delay between the two tests of more than 1 week (n = 12)
or a failure to obtain a technically adequate CTV because
of hip and knee prostheses (n = 1). This left 136 patients
for review. Approval of this investigation was granted by
the University of Michigan Medical School Institutional
Review Board for Human Subject Research (#2000-
0643).
Deep venous thrombosis (DVT) affects 84 of every
100,000 people in the United States1 and is responsible
for 300,000 to 600,000 hospitalizations annually.2
Pulmonary embolus (PE) is a sequelae of DVT that is
responsible for as many as 200,000 deaths each year.3
Duplex ultrasound scanning (US) is the current accepted
standard for the diagnosis of lower-extremity (LE) DVT.4
The sensitivity and specificity rates of US for supragenicu-
late LE-DVT are both greater than 90%.5-9
Computed tomographic venography (CTV), which
was first described in 1994,10 is an alternative imaging
modality for the diagnosis of LE-DVT that may be per-
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Purpose: Duplex ultrasound scanning (US) is the accepted standard means of diagnosis for lower-extremity supra-
geniculate deep venous thrombosis (LE-DVT). Computed tomographic venography (CTV) has been proposed as an
alternative modality for diagnosis of LE-DVT in patients with suspected pulmonary embolism (PE). This study com-
pared CTV with US as a means of diagnosing acute LE-DVT.
Methods: A retrospective review of US and CTV scans from 136 patients with suspected PE who underwent both stud-
ies to exclude acute LE-DVT at a single institution was performed. Studies were reviewed and coded in a blinded man-
ner. US was considered to be the reference test. Direct costs of each study were determined by using commercial
software.
Results: The sensitivity and specificity rates of CTV were 71% and 93%, respectively. The positive predictive value, neg-
ative predictive value, and accuracy rates of CTV were 53%, 97%, and 90%, respectively. DVT localization was the same
in eight of 10 cases in which the results of both US and CTV were positive. CTV costs and charges per study were
greater than those of US by $46.88 and $602.00, respectively.
Conclusion: CTV is specific, but has a lower sensitivity rate and positive predictive value for the diagnosis of acute LE-
DVT compared with US. Additionally, CTV is more costly than US scanning. Because of the lower sensitivity rate and
positive predictive value and the increased cost of CTV, US remains the screening study of choice in cases of suspected
acute LE-DVT. (J Vasc Surg 2001;34:798-804.)
Because this project addressed acute DVT, readings in
which a thrombosis was chronic were coded as negative.
This criteria affected five studies (3 US and 2 CTV).
Ultrasound scanning. US was performed in an
accredited (Intersocietal Commission for the Accre-
ditation of Vascular Laboratories) vascular laboratory by
vascular technologists. Gray-scale and color images of the
external iliac, common femoral, femoral, and popliteal
veins were obtained by means of a Powervision 6000,
Sonolayer (Toshiba America Medical Systems, Tustin,
Calif) or HDI 3000 CV (ATL, Bothell, Wash) with 5- to
7.5-MHZ linear array transducers. Positive diagnostic cri-
teria for acute DVT included an enlarged non-compress-
ible hypoechoic vein and absence of Doppler signal and
color flow. Positive criteria for chronic DVT with US
included a non-enlarged hyperechoic vein. Scans were
interpreted by vascular technologists, and then the results
were confirmed by physicians blinded to the results of
CTV and CTPA.
Computed tomographic venography. CTV was
obtained with a Lightspeed Qxi scanner (General Electric
Medical Systems, Milwaukee, Wis). The protocol for
acquiring images included an intravenous infusion of 150
mL of nonionic iohexol (Omnipaque-300; Nycomed-
Amersham, Princeton, NJ) at a rate of 4 mL/s. Scanning
commenced 3 minutes after contrast administration and
extended from the iliac crests to 1 cm below the tibial
plateaus (tibial veins were not imaged with CTV).
Imaging was performed at 7.5 mm collimation with a
table speed of 22.5 mm per rotation. Scan data were
reconstructed at 3.75-mm intervals. Positive diagnostic
criteria for acute DVT included the presence of filling
defects and venous dilatation. Positive criteria for chronic
DVT with CTV included the presence of filling defects
that were web- or thread-like, peripherally located, or cal-
cified. CTV images were read by radiologists blinded to
the results of US. Cases in which US and CTV readings
did not agree were later re-reviewed to define reasons for
the discordance.
Statistical analysis. Sensitivity, specificity, positive
and negative predictive values, and accuracy for CTV of
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the external iliac, common femoral, femoral, and popliteal
veins were calculated by using US as the reference.
Cost analysis. ICD-9 (International Classification of
Diseases, Ninth Revision) codes were identified for each
test (CTV of the pelvis and LE and US of the LEs). Cost
data for these codes at our institution were generated by
an independent analyst with Transition Systems software
(Eclipsys Corporation, Delray Beach, Fla). Cost data
reflect direct costs alone and do not include professional
expenses.
Table I. Comparison of ultrasound scanning and com-
puted tomographic venography for suspected lower-
extremity deep venous thrombosis in patients with
suspected pulmonary embolus
Positive US Negative US
Positive CTV 10 (7%) 9 (7%)
Negative CTV 4 (3%) 113 (83%)
Sensitivity rate, 71% (10/[10 + 4] × 100)
Specificity rate, 93% (113/[9 + 113])
Positive predictive value, 53% (10/[10 + 9])
Negative predictive value, 97% (113/[113 + 4])
Accuracy rate, 90% ([10 + 113]/136)
US, Ultrasound scanning; CTV, computed tomographic venography.
A
B
Fig 1. Concordant results: positive US and positive CTV (true
positive). A, Non-compressible femoral vein shown by means of
US. B, Filling defect in the femoral vein shown by means of CTV
in the same patient.
RESULTS
The 136 study patients were all inpatients, with a mean
age of 59.5 years (range, 16-90 years). There were 54 men
(40%) and 82 women (60%). All studies were performed in
the setting of suspected PE (n = 136, 100%). PE was diag-
nosed by means of CTPA in 40 patients (29%). On aver-
age, US preceded CTV by 3.7 hours (range, 0-7 days).
Compared with US, CTV was 71% sensitive and 93%
specific. CTV also had a positive predictive value of 53%,
a negative predictive value of 97%, and an accuracy rate of
90% (Table I). DVT localization was the same in eight of
10 true-positive cases (Fig 1). In one of the two true-pos-
itive cases in which DVT localization was discordant, a
clot in the superficial femoral vein was shown by means of
CTV, whereas thrombosis in the femoral and popliteal
veins was shown by means of US. In the other case,
thrombosis was demonstrated in the femoral vein with
CTV, and thrombosis was demonstrated in the external
iliac and femoral veins with US.
The discordant studies deserve particular note (Table
II). On re-review of the US results in the false-positive
cases (Fig 2), five cases showed no convincing evidence of
DVT, three cases lacked full compression of the vein in
question, and one case had a filling defect that was not
JOURNAL OF VASCULAR SURGERY
800 Peterson et al November 2001
Table II. Discordant ultrasound scanning and computed tomographic venography results
Time between CTV Location and CTPA results
Patient studies (days) US results results Possible reason for discordance nature of DVT (PE)
1 0 Positive Negative CT images in arterial phase. No venous SFV and POP B Positive
opacification with contrast. US convincing 
+DVT.
2 0 Positive Negative CT shows extensive bilateral aortic through R SFV Negative
popliteal calcification. Likely caused delayed 
contrast and therefore delayed opacification. 
US convincing +DVT.
3 0 Positive Negative CT shows streak artifact secondary to L SFV Positive
L femoral hardware making part of FEM 
not visible. US convincing +DVT.
4 0 Positive Negative CT did not visualize distally in POP secondary R POP Negative*
to poor contrast bolus. US convincing +DVT.
5 1 Negative Positive CT images very noisy due to patient size. B profunda Positive
Convincing clot in B profunda FEM and POP. FEM and POP
US does not examine profunda FEM. L POP 
not compressible, but positive flow R POP. 
Convincing no DVT.
6 0 Negative Positive CT contrast and images show convincing DVT. L SFV Positive
US L SFV not fully compressible secondary 
to Hunter’s canal.
7 1 Negative Positive CT images show asymmetric contrast L CFV and SFV Positive
secondary to R BKA with good vein 
enhancement on R and no contrast on L, 
therefore likely confused for L LE clot. 
US L CFV convincing no DVT, L SFV 
not fully compressible secondary to 
body habitus.
8 0 Negative Positive CT images with convincing DVT. L SFV Positive
US unavailable for review; however, images 
show L SFV compressible and dopplerable.
9 1 Negative Positive CT in arterial phase. US convincing no DVT. L POP Negative
10 7 Negative Positive CT primarily read as bilateral DVT from B SFV and POP Negative
B SFV to B POP. Not able to be 
re-reviewed. US convincing no DVT.
11 0 Negative Positive CT suggest DVT on only 1 image. R FEM Negative
US convincing no DVT.
12 0 Negative Positive CT difficult to obtain images to re-review. R POP Positive
US suggests that possible filling defect in R POP.
13 1 Negative Positive CT bolus is during arterial phase with poor L POP Negative
venous enhancement that may have been 
mistaken for DVT.
US convincing no DVT.
*CTPA poor contrast bolus and marked atelectasis. Recommend if “clinical suspicion for a PE is high, pulmonary angiography is suggested for further eval-
uation.”
US, Ultrasound scanning; CTV, computed tomographic venography; DVT, deep venous thrombosis; B, ; SFV, superficial femoral vein; POP, popliteal vein;
R, right; FEM, femoral vein; L, left; CFV, common femoral vein; BKA, below-knee amputation; LE, lower extremity.
recognized initially. Re-review of the false-positive CTV
results documented three cases in which the DVT was
convincing, two cases in which the contrast bolus was pri-
marily in the arterial phase, one case of an asymmetric vein
enhancement after a below-knee amputation, and one case
in which there was only a filling defect on a single image.
There were two cases in which CTV images were unavail-
able for re-review. PE was diagnosed by means of CTPA in
five of the nine false-positive cases (56%). 
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On re-review of the US results in the false-negative
cases (Fig 3), all studies were convincing for an acute
DVT. The four false-negative CTV scans demonstrated
two cases of arterial inflow problems and incomplete mix-
ing of blood and contrast, one case of image distortion
caused by femoral hardware, and one case in which a DVT
in the popliteal vein that was identified by means of US
was more distal than the CTV scanned. PE was diagnosed
by means of CTPA in two of four false-negative cases
A
B
Fig 2. Discordant results: negative US and positive CTV (false
positive). A, Normal compression of the femoral vein shown by
means of US. B, Filling defect in the femoral vein shown by
means of CTV, caused by means of incomplete mixing of blood
and contrast, in the same patient. 
A
B
Fig 3. Discordant results: positive US and negative CTV (false
negative). A, Non-compressible popliteal vein shown by means of
US. B, No filling defect in the popliteal vein shown by means of
CTV, caused by insufficient contrast because of inflow disease, in
the same patient.
(50%). In addition, the CTPA results were equivocal but
read as negative in another case. No pulmonary arteri-
ogram was performed in this case.
The cost of pelvis and LE CTV was $109.70, whereas
the bilateral LE US cost was $62.82, a difference of
$46.88. For the 136 patients studied, CTV cost
$6,375.68 more than US. The charge for pelvis and LE
CTV was $1066.00, whereas the bilateral LE US charge
was $464.00, a difference of $602.00. Thus, CTV
summed charges were $81,872.00 more overall for the
136 patients reviewed.
DISCUSSION
These data suggest that CTV is specific, but has a
lower sensitivity rate and positive predictive value than US
for acute LE-DVT in patients with suspected PE. In addi-
tion, this study demonstrates that the direct costs of CTV
are greater than those of US.
Several earlier projects compared CTV with US for the
diagnosis of LE-DVT (Table III). In a retrospective review
of 74 patients by Duwe and colleagues, CTV had sensitiv-
ity and specificity rates of 89% and 94%, respectively. The
positive and negative predictive values in their experience
were 67% and 98%, and the accuracy of CTV was 93%.12
In a prospective study of 70 consecutive patients by Garg
and colleagues, CTV had sensitivity and specificity rates of
100% and 97%, respectively, and positive and negative pre-
dictive values of 71% and 100%, respectively.13 Two other
prospective studies by Loud14 and Cham15 reported sen-
sitivity rates of 100% and specificity rates ranging from
96% to 100%. Some of the cited study results, the sensi-
tivity values in particular, are at variance with those
presently reported.
There are a number of potential reasons for the rela-
tively low sensitivity rate in this study. First, the absence of
standardized CTV diagnostic criteria may be a factor in
relating differences in all of the earlier studies. Second, the
lack of standardized CTV protocols may lead to divergent
findings. For example, Yankelevitz and colleagues studied
CTV optimization of venous enhancement, finding peak
enhancement 2 minutes after contrast administration.16
The three prospective studies by Garg, Loud, and Cham
had delay times ranging from 20 seconds to 3.5 minutes,
whereas the retrospective study by Duwe used a 2-minute
delay. The delay in this series was 3 minutes. Additional
differences in scan interval and the amount and type of
contrast used may have contributed to the discrepancy in
sensitivity among the various studies.
The lack of a venographic standard for DVT diagnosis
against which to compare both US and CTV is a potential
limitation of this study.12,13,17 Ascending venography,
which has been considered to be the venographic standard,
is limited by high costs, interobserver variation, inability to
perform the test in a significant number of patients, and
radiation exposure.17,18 Furthermore, the high sensitivity
and specificity rates of US for the diagnosis of supragenic-
ulate DVT have lead to the acceptance of US as the stan-
dard, replacing venography in most practices. 
It is important to examine the implications should the
decision to give anticoagulants be made on the basis of CT
(CTV and CTPA) alone. Among the nine cases in which
CTV was falsely positive, five patients had positive results
with CTPA, which would have led to four patients who
would have been given anticoagulants had CTV and
CTPA been used alone. Among the four cases in which
CTV was falsely negative, two patients had positive results
with CTPA, which would have caused two patients to be
inadequately treated if only CTV and CTPA had been
obtained. Of the 136 patients in this study, six patients
(4.4%) would have been inappropriately treated if CTV
and CTPA had been used without US.
Examination of cost data revealed the direct costs per
study for CTV to be $46.88 (75%) greater than those for
US. It is important to note that this analysis is not one of
cost-effectiveness. As an initial analysis of the differences in
costs, the data presented here support the tenet that CTV
is more costly than US.
Despite several limitations, CTV may prove beneficial
in certain circumstances. CTV permits assessment of the
common iliac veins and the inferior vena cava (IVC) and,
therefore, may be of use in examining patients with sus-
pected DVT in these veins. For example, patients with sus-
pected PE and negative US results may benefit from CTV
after CTPA as a means of excluding IVC or common iliac
vein thromboses.
Although CTV has been proposed as a single, rapid
test for the diagnosis of both PE and DVT, using no more
intravenous contrast than needed for the CTPA portion of
the examination, this study suggests CTV adds cost with-
out improving the sensitivity rate or positive predictive
value. Presently, the low sensitivity rate and positive pre-
dictive value of CTV does not support its use as the
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Table III. Series comparing ultrasound scanning with computed tomographic venography for the diagnosis of lower-
extremity deep venous thrombosis
Author Year N Study design Sensitivity Specificity PPV NPV
Duwe12 2000 74 Retrospective 89% 94% 67% 98%
Garg13 2000 70 Prospective 100% 97% 71% 100%
Loud14 2000 71 Prospective 100% 100% NR NR
Cham15 2000 116 Prospective 100% 96% NR NR
Peterson 2001 136 Retrospective 71% 93% 53% 97%
PPV, Positive predictive value; NPV, negative predictive value; NR, not reported.
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screening test of choice for acute LE-DVT. As the diag-
nostic parameters for CTV are refined and more techni-
cally advanced scanners become available, the sensitivity of
this test should improve. At present, however, US remains
the standard for the diagnosis of acute LE-DVT.
We thank the University of Michigan Diagnostic
Vascular Unit and Department of Radiology staff, who
cared for the patients reported in this study, and Louisa
Griffes of the University of Michigan Clinical Information
and Decision Support Services for assistance with the cost
analysis.
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Dr Patricia Thorpe (Omaha, Neb). Congratulations to the
entire group from Michigan who has given him support for
preparing and presenting this paper, which I very much enjoyed.
It reminds me of when we were doing arch studies and compar-
ing them to CT early on. There was always a discussion about
trauma arch studies and whether or not one needed to go to
angiography or do a CAT scan. It is analogous in the way that the
arch CT can miss a lesion when there is too much or not enough
contrast or when the lesion is small and you are cutting around
the lesion. A negative arch CT does not really help if you are really
suspicious of a traumatic dissection in the arch. On the other
hand, a positive study does help and maybe preclude going to
angiography. In some ways the issue with CT for DVT is similar.
This modality was never designed to rule out DVT, although it
has been applied to the pulmonary bed and thin cuts have helped
in studying lungs and avoiding pulmonary angiography in certain
patients. Extension of this modality into the venous periphery, I
think, is a little bit of a stretch. In the periphery sometimes there
is DVT and without contrast around the thrombus, the study
looks negative. On some of the studies I think that you showed
there is too much contrast so it does not show the thrombus sit-
ting in the popliteal. So the contrast issue can produce false neg-
ative or false positive findings.
On the other hand, Mr Peterson, your careful analysis of all
the misses shows us a lot of information about how even ultra-
sound is not perfect for DVT. These data can help everyone
improve their studies.
What I would like to point out as well is that this study is very
valuable for the cost data analysis. To me it is intuitive that CT is
not the study of choice for DVT, and maybe I am biased because
I do a lot of venography. On the other hand, I think your data will
decrease what I think is a rush to do “quick and dirty” venograms
with CT, which I think is unwarranted and too expensive. This
leads me to one of the questions that I am going to ask you. You
had 113 patients that had negative studies in both ultrasound and
CT. It would be interesting to know if you followed that group
to see how many of those people actually ended up with either a
subsequent DVT or pulmonary embolus. Would like to know
how much it costs to miss a patient with DVT.
The other is, you state that you think that the sensitivity might
increase if you did more exams, and I am not sure how or why you
think that at your institution. If you started doing more CT exams
for the periphery, why would that increase the sensitivity per se?
And most of the CT misses are in the thigh and the popliteal
veins. I think I might have alluded to why I think that is the case,
but if you have any other thoughts about why most of the misses
are there, could you tell us?
And then last of all, if someone in your family actually had to
rule out a pulmonary embolus and the ultrasound was negative
and then you had in fact a negative CT scan, what would you do?
DISCUSSION
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It was an honor to be able to discuss this paper. It is very well
written, and I think it is an important contribution to our litera-
ture. Thank you very much.
Mr David A. Peterson. Thank you, Dr Thorpe, for your
thoughtful comments and questions.
Regarding the first question, specifically how many of 113
patients who had negative ultrasound and CT venograms later
developed DVT or PE, we did not look at these data. It may
prove difficult to establish if a subsequent DVT or PE was missed
by ultrasound and CT venography, or whether it developed fol-
lowing the initial imaging. Because ultrasound and CT venogra-
phy are specific for DVT, we feel having both studies negative
makes it a near certainty that the patient did not have a DVT,
despite the lack of a venographic standard.
Secondly, you asked why we feel the sensitivity of CT venog-
raphy might increase if more studies were performed. The para-
meters for doing the study including things like the delay between
administration of contrast and scanning, the types of contrast
used, the intervals used for reconstruction are subject to debate.
In that way, doing more studies and learning what the parameters
for the study should be would improve the sensitivity.
The third question concerned reasons for the finding that
most discordant CT studies occurred in the thigh and popliteal
veins. The discordant studies in our project were all in either the
femoral or popliteal veins. Because most of the imaging occurred
in the femoral and popliteal veins, only the external iliac veins had
no discordant studies, it is not unexpected that these were the
locations where US and CT venography disagreed.
Finally, if a relative had a suspected PE or a suspected DVT,
would I recommend CT venography? I think that what our study
has shown is that CT venography is specific for DVT, meaning
CT venography does a good job excluding DVT. However, in the
case of a positive study, I would be wary to anticoagulate based
on that finding alone, given the low sensitivity and positive pre-
dictive value of the test. The message from this study, particularly
in the case of a positive CT venogram, is that we are obligated to
correlate the finding with ultrasound.
I thank the Forum for the honor of speaking today.
Unidentified speaker. I would like to restate Dr Thorpe’s
question about the location of the thrombi because it is known
that duplex ultrasound has a different accuracy, both sensitivity
and accuracy, for deeper segments, so why do you feel comfort-
able to compare all segments all together with duplex ultrasound
using it as a gold standard?
Mr Peterson. We feel that from the external iliac to the
popliteal veins ultrasound is the gold standard and serves as a ref-
erence test for which to compare CT venography or any other
study, and know this idea has been well supported in the literature.
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